218 related articles for article (PubMed ID: 23731603)
1. [Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease].
Rasolofo J; Poncelet M; Rousseau V; Marec-Berard P
Arch Pediatr; 2013 Jul; 20(7):762-7. PubMed ID: 23731603
[TBL] [Abstract][Full Text] [Related]
2. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
Yaster M; Tobin JR; Billett C; Casella JF; Dover G
Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
[TBL] [Abstract][Full Text] [Related]
3. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
[TBL] [Abstract][Full Text] [Related]
4. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso-occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study.
Rousseau V; Morelle M; Arriuberge C; Darnis S; Chabaud S; Launay V; Thouvenin S; Roumenoff-Turcant F; Metzger S; Tourniaire B; Marec-Berard P
Pain Pract; 2018 Jul; 18(6):788-797. PubMed ID: 29266772
[TBL] [Abstract][Full Text] [Related]
6. A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease.
Trentadue NO; Kachoyeanos MK; Lea G
J Pediatr Nurs; 1998 Feb; 13(1):15-9. PubMed ID: 9503762
[TBL] [Abstract][Full Text] [Related]
7. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
8. Quantification of analgesic use in children with sickle cell disease.
Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639
[TBL] [Abstract][Full Text] [Related]
9. Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease.
Goldman RD; Mounstephen W; Kirby-Allen M; Friedman JN
Pediatrics; 2013 Dec; 132(6):e1634-41. PubMed ID: 24276838
[TBL] [Abstract][Full Text] [Related]
10. Postoperative morphine consumption in children with sickle-cell disease.
Crawford MW; Galton S; Naser B
Paediatr Anaesth; 2006 Feb; 16(2):152-7. PubMed ID: 16430411
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
12. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
13. Tramadol infusion for the pain management in sickle cell disease: a case report.
Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
[TBL] [Abstract][Full Text] [Related]
15. Effects of 3 analgesic regimens on the perception of pain after removal of femoral artery sheaths.
Fulton TR; Peet GI; McGrath MA; Hilton JD; Smith RE; Sigurdsson AF; Forrest QG
Am J Crit Care; 2000 Mar; 9(2):125-9. PubMed ID: 10705425
[TBL] [Abstract][Full Text] [Related]
16. Management of vaso-occlusive pain in children with sickle cell disease.
Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
J Pediatr Hematol Oncol; 2003 Apr; 25(4):307-11. PubMed ID: 12679645
[TBL] [Abstract][Full Text] [Related]
17. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
[TBL] [Abstract][Full Text] [Related]
18. Pre-emptive analgesia with ketamine, morphine and epidural lidocaine prior to total knee replacement.
Wong CS; Lu CC; Cherng CH; Ho ST
Can J Anaesth; 1997 Jan; 44(1):31-7. PubMed ID: 8988821
[TBL] [Abstract][Full Text] [Related]
19. Does intrathecal morphine sulfate provide preemptive analgesia for patients undergoing stapled hemorrhoidopexy?
Fader JP; Cleary RK; Lampman RM; Winter S; Singal BM; Plona AE
Pain Med; 2011 Feb; 12(2):322-7. PubMed ID: 21266003
[TBL] [Abstract][Full Text] [Related]
20. Intranasal diamorphine for acute sickle cell pain.
Telfer P; Criddle J; Sandell J; Davies F; Morrison I; Challands J
Arch Dis Child; 2009 Dec; 94(12):979-80. PubMed ID: 19321506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
